These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31576166)

  • 1. miR-140-5p Alleviates The Aggressive Progression Of Wilms' Tumor Through Directly Targeting
    Cancer Manag Res; 2019; 11():8605. PubMed ID: 31576166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-140-5p alleviates the aggressive progression of Wilms' tumor through directly targeting
    Wang H; Lou C; Ma N
    Cancer Manag Res; 2019; 11():1641-1651. PubMed ID: 30863174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cancer Manag Res; 2021; 13():7645-7646. PubMed ID: 34675660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction].
    Cancer Manag Res; 2023; 15():1267-1268. PubMed ID: 38027244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircCDYL Acts as a Tumor Suppressor in Wilms' Tumor by Targeting miR-145-5p.
    Zhou R; Jia W; Gao X; Deng F; Fu K; Zhao T; Li Z; Fu W; Liu G
    Front Cell Dev Biol; 2021; 9():668947. PubMed ID: 34485273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction].
    Cancer Manag Res; 2023; 15():487-488. PubMed ID: 37325187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA LINC01783 Promotes the Progression of Cervical Cancer by Sponging miR-199b-5p to Mediate GBP1 Expression [Retraction].
    Cancer Manag Res; 2022; 14():967-968. PubMed ID: 35283646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction].
    Cancer Manag Res; 2022; 14():3457-3458. PubMed ID: 36545223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis [Retraction].
    Cancer Manag Res; 2023; 15():979-980. PubMed ID: 37693223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CircCRIM1 Inhibits HDAC4 to Impede Osteosarcoma Proliferation, Migration, and Invasion and Facilitate Autophagy by Targeting miR-432-5p [Retraction].
    Cancer Manag Res; 2023; 15():1007-1008. PubMed ID: 37727811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative RT-PCR-based miRNA profiling of blastemal Wilms' tumors from formalin-fixed paraffin-embedded samples.
    Buglyó G; Magyar Z; Romicsné Görbe É; Bánusz R; Csóka M; Micsik T; Berki Z; Varga P; Sápi Z; Nagy B
    J Biotechnol; 2019 Jun; 298():11-15. PubMed ID: 30959135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.
    Wang HF; Zhang YY; Zhuang HW; Xu M
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3360-3369. PubMed ID: 28829507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1.
    Zhao XS; Han B; Zhao JX; Tao N; Dong CY
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6826. PubMed ID: 34859841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p [Retraction].
    Cancer Manag Res; 2021; 13():7251-7252. PubMed ID: 34584451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
    Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
    Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p [Retraction].
    Cancer Manag Res; 2021; 13():9347-9348. PubMed ID: 34992458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine Suppresses Cell Proliferation and Aerobic Glycolysis by Regulating circHOMER1/miR-138-5p/HEY1 Axis in Colorectal Cancer [Retraction].
    Cancer Manag Res; 2020; 12():7341. PubMed ID: 32904149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.